How Long Do Ozempic Side Effects Last?

See if you qualify in 5 minutes →
5-minute questionnaire · reviewed by a licensed clinician · Nouri Promise: full refund in your first 30 days on 3-month and 6-month plans · cancel anytime

At a glance: side-effect duration by symptom

Side effect	Typical duration	Notes
Nausea	~8 days per episode (median)	Eases over the first weeks; returns briefly after dose increases
Diarrhea	~3 days per episode	Usually short-lived
Vomiting	~2 days per episode	Call a clinician if you cannot keep fluids down
Constipation	Longer (weeks)	Lingers more than other GI effects; proactive management helps
Overall adjustment	~6–12 weeks at a stable dose	Most people settle in this window, then reset briefly at each new dose step

Duration figures are from trials of the FDA-approved branded medications (Wegovy prescribing label, Wharton et al. 2022) and are averages, not individual predictions. Compounded semaglutide was not studied in these trials. Information is current as of June 2026.

The honest answer: usually, but not always

For the large majority, the common GI side effects are transient. They peak early and after dose increases, then improve as your body adjusts, typically over 6–12 weeks at a steady dose. But it is not universal. Symptoms can briefly return at each new dose step, constipation tends to last longer than the other effects, and a small percentage (~4–7%) of people in clinical trials of the branded medications discontinued because of side effects they could not tolerate. If that's where you are, that's worth a direct conversation with your clinician — it doesn't mean GLP-1 therapy is impossible, but your titration schedule may need adjusting.

The side-effect data in this article comes from trials of branded FDA-approved semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro). Compounded semaglutide and tirzepatide were not studied in these trials, are not FDA-approved, and are not the same as the brand-name drugs. The underlying mechanism is the same GLP-1 receptor agonism, but outcomes at the individual level will vary.

How long does each side effect last?

The clearest published data on duration comes from a 2022 review of GLP-1 receptor agonist tolerability in clinical practice (Wharton et al., PMC 2022). Individual episodes lasted a median of about 8 days for nausea, 3 days for diarrhea, and 2 days for vomiting, while constipation lasted considerably longer. The STEP 1 trial of semaglutide 2.4 mg (the molecule in Wegovy) confirmed that nausea was the most common adverse event, reported in roughly 44% of participants, and was predominantly mild to moderate — consistent with the short episode-duration data (Wilding et al., NEJM 2021).

For tirzepatide (the molecule in Zepbound), the SURMOUNT-1 trial found nausea in approximately 25–29% of participants, with a broadly similar temporal pattern — worst early and after each dose increase (Jastreboff et al., NEJM 2022). Tirzepatide's GI side-effect burden is generally reported as somewhat lower than semaglutide's at equivalent weight-loss doses, though head-to-head comparisons are limited. See our full guide to Mounjaro and Zepbound side effects for the tirzepatide-specific data.

For a deeper dive on the most common symptom, see our dedicated guide to Ozempic nausea and our guide to Ozempic constipation, which covers the longer-lasting GI effect most people don't anticipate.

Why do side effects return after each dose increase?

GLP-1 receptor agonists slow gastric emptying and act on GI receptors in ways the body has not yet adapted to. At a stable dose, most people develop tolerance — the body's response quiets down. When the dose steps up, the body is exposed to a higher level of drug effect and essentially re-adapts from a new baseline, causing a brief recurrence of the same GI symptoms. This is expected and predictable, not a sign that something is wrong. The STEP 4 trial, which looked at what happens to people who stay on semaglutide long-term, confirmed that side effects attenuate at steady state (Rubino et al., JAMA 2021). Each adjustment period is generally shorter than the one before it as your system learns to anticipate the drug.

What helps Ozempic side effects resolve faster?

Slow titration is the biggest lever — most prolonged or severe GI side effects happen when the dose is escalated too quickly. Other evidence-based strategies:

• Eat smaller meals. A full stomach amplifies nausea; small, frequent, low-fat meals reduce it.
• Stay hydrated. GI losses (nausea, diarrhea) combined with reduced appetite can lead to dehydration, which worsens fatigue and dizziness.
• Address constipation early. It's the side effect most likely to persist. Adequate fiber, hydration, and gentle movement matter more here than for the acute GI effects.
• Time your injection. Some people find injecting at night reduces the peak-nausea window to sleeping hours.
• Talk to your clinician. If side effects aren't easing after several weeks at a stable dose, a dose hold or slower titration schedule often resolves the problem.

The NIH NIDDK guidance on prescription weight-loss medications notes that GI side effects are typically the primary reason people discontinue GLP-1 therapy — and that they are largely manageable with the titration adjustments described above.

For a week-by-week breakdown of what to expect when you start, see Starting Ozempic: What to Expect. For the full spectrum of side effects — including the serious ones — see our cluster hub: Ozempic / Semaglutide Side Effects (complete list).

When should you call your clinician?

Most GI side effects are uncomfortable but not dangerous. The situations that warrant prompt clinical contact:

• You cannot keep fluids down (vomiting for more than 24 hours).
• Significant abdominal pain that is new or worsening — not just nausea.
• Signs of dehydration: dark urine, dizziness on standing, confusion.
• Side effects that are not improving after several weeks at a stable dose.

For the full red-flag list — including the less common but serious risks — see Serious Ozempic Side Effects and Warnings.

How Nouri helps you manage side effects

The single biggest factor in side-effect duration is slow dose titration — and that's a care-team decision, not just an instruction. Nouri includes ongoing support from U.S.-licensed clinicians who can slow your titration schedule, adjust your plan when symptoms flare, and help you stay on track through the adjustment period. The Program also includes a personalized nutrition plan designed in part around the GI side effects of GLP-1 therapy (smaller portions, higher protein, lower-fat meals during titration).

When prescribed, The Program includes compounded semaglutide starting from $120/month (on the 6-month plan, $720 billed every 6 months) or compounded tirzepatide starting from $175/month (on the 6-month plan, $1,050 billed every 6 months) — all-inclusive, any dose, same price. Compounded GLP-1 medications are not FDA-approved and are not therapeutically equivalent to Wegovy, Ozempic, Zepbound, or Mounjaro. Medication is prescribed only if clinically appropriate after review by a U.S.-licensed provider — not all applicants qualify.

Backed by the Nouri Promise: if you're not satisfied in your first 30 days, you get a full refund — available on 3-month and 6-month plans.

Start your 5-minute assessment →
5-minute questionnaire · reviewed by a licensed clinician · Nouri Promise: full refund in your first 30 days on 3-month and 6-month plans · cancel anytime

Frequently asked questions

How long do Ozempic side effects last?

For most people they're temporary — worst early or after a dose increase, then easing over weeks, usually settling within about 6–12 weeks at a stable dose. Individual episodes are shorter (nausea ~8 days, diarrhea ~3, vomiting ~2); constipation lingers longer.

Do Ozempic side effects go away?

Usually, but not always. They tend to improve as your body adjusts, though they can return briefly after each dose increase, constipation can persist, and a small percentage of people stop the medication due to side effects they can't tolerate.

When do Ozempic side effects stop?

Most people see them settle within about 6–12 weeks at a steady dose, with brief flare-ups after each dose increase along the way.

Do side effects get better over time on Ozempic?

Yes, for most people — the common GI side effects generally attenuate as the body adapts to a stable dose. Slow titration helps them resolve faster.

How long until your body adjusts to Ozempic?

Commonly several weeks to a few months — many people feel adjusted within 6–12 weeks at a stable dose, though it varies by person and resets somewhat at each dose increase.

How long do Wegovy or Mounjaro side effects last?

The same pattern — worst right after each dose increase, then settling over roughly 6–12 weeks at a stable dose. The timeline is driven by the drug class, not the specific brand.

Sources & references

1. Wharton S et al. GLP-1 receptor agonist tolerability: duration of GI side effects in clinical practice (2022, PMC) — Tier 2
2. Wegovy (semaglutide) FDA prescribing label — adverse reactions section — Tier 1
3. Zepbound (tirzepatide) FDA prescribing label — Tier 1
4. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021 — Tier 1
5. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM 2022 — Tier 1
6. Rubino DM et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4). JAMA 2021 — Tier 1
7. NIH NIDDK — Prescription Medications to Treat Overweight and Obesity — Tier 1

Medically reviewed by Amber Patel, MD · June 28, 2026. Nouri content is reviewed by licensed clinicians and updated as guidance changes. Author: Nouri Editorial Team.

This article is general information, not individual medical advice — talk to your clinician about your symptoms, and seek urgent care for the red-flag symptoms described here. Side-effect rates and duration data come from clinical trials of the FDA-approved branded medications (Wegovy, Zepbound, semaglutide 2.4 mg); compounded semaglutide and tirzepatide were not studied in these trials, are not FDA-approved, and are not the same as, or therapeutically equivalent to, the brand-name drugs. GLP-1 medications carry a boxed warning for thyroid C-cell tumors and are contraindicated with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Ozempic®, Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk; Mounjaro® and Zepbound® are registered trademarks of Eli Lilly. Nouri is not affiliated with these companies. Information is current as of June 2026.